Methods: A total of 174 patients (124 males, 50 females; mean age 58.2±10.4 years; range, 33 to 78 years) with a Body Mass Index of ≥30 kg/m2 undergoing cardiac surgery via median sternotomy between January 2011 and December 2015 in our institution were retrospectively analyzed. Of the patients, 94 were inserted a Jackson-Pratt drain (JP group) following median sternotomy, while 80 patients received no drain (non-JP group). Pre-, intra, and postoperative outcomes of both groups including type of operation, length of hospital stay, and complications were compared.
Results: No significant difference in the age, gender, Body Mass Index, and potential risk factors was found between the groups. The median of stay in the intensive care unit was two days and the median time from operation to discharge was seven days in both groups. There was a statistically significant difference in the rate of sternal wound complications between the groups. Sternal wound complications occurred in two patients (2.1%) in the drained group, compared to nine patients (11.25%) in the non-drained group (p=0.01).
Conclusion: Our study results show that Jackson-Pratt drain insertion after median sternotomy in patients with a Body Mass Index of ≥30 kg/m2 undergoing open cardiac surgery is a simple and reliable method to reduce the risk of postoperative sternal wound complications, compared to the conventional closure technique.
In the present study, we hypothesized the insertion of the JP drain would be helpful in preventing fluid (blood or other) build-up in a closed space during healing and in reducing the risk of SWCs. We aimed to investigate the effect of the JP drain on SWCs in patients with BMI ≥30 kg/m2 undergoing cardiac surgery via median sternotomy.
A written informed consent was obtained from each patient. The study protocol was approved by the Okan University Hospital Ethics Committee. The study was conducted in accordance with the principles of the Declaration of Helsinki.
Jackson-Pratt drain
The JP drain is a closed-suction medical device
which is commonly used as a postoperative drain
to collect body fluids from the surgical sites. The
device consists of an internal drain connected to a
grenade-shaped bulb via plastic tubing. The JP drain
(informally referred to as brain drain) was named after
its inventors Drs. Fredrick E. Jackson and Richard A.
Pratt. First publications mentioning this device date
back to 1971 - 1972.[5,6] The purpose of this drain is
to prevent fluid (blood or other) build-up in a closed
space which may cause either disruption of the wound
and the healing process or become an infected abscess.
The drain pulls this fluid (by suction) into a bulb.
The resulting vacuum creates suction in the drainage
tubing, which gradually draws fluid from the surgical
site into the bulb. The bulb may be repeatedly opened
to remove the collected fluid and squeezed again to
restore suction. The JP drains come in flat and round
forms and are available in varying sizes.
Surgical technique
Median sternotomy was performed in the conventional
fashion. In all patients, after completion of the cardiac
procedures and achievement of hemostasis, the standard
closure of the median sternotomy involved the use
of peri-sternal, single or figure-of-eight sternal wires
with a multi-twist closure. The suturing technique and
material for both subcuticular and subcutaneous closures
were identical in all patients. The presternal fascia and
muscle were reapproximated with size 0 polyglactin
910 suture (Vicryl, Ethicon, Inc., Somerville, NJ, USA)
applied in a continuous fashion. The JP drain was
inserted at this stage of the operation. Firstly, the skin
is opened with a 15 blade. A 14F diameter JP silicone
flat drain was inserted easily through this small opening
in a suprasternal fashion. The subcutaneous tissue was
reapproximated with 2-0 polyglactin 910 suture (Vicryl,
Ethicon, Inc., Somerville, NJ, USA) and the skin was
closed with a subcuticular 3-0 poliglecaprone 25 suture
(Monocryl, Ethicon, Inc., Somerville, NJ, USA), both
applied in continuous fashion in all patients. A sterile
island-type bandage was, then, applied (Figure 1).
Superficial sternal wound infection was defined as infection limited to skin, subcutaneous tissue, and pectoral fascia. Deep sternal wound infection was defined as the presence of one of the following criteria: (i) an organism isolated from culture of mediastinal tissue or fluid; (ii) e vidence o f m ediastinitis d uring operation; or (iii) presence of either chest pain, sternal instability or fever (>38°C), and either purulent drainage from the mediastinum, isolation of an organism present in blood culture or culture of the mediastinal area.[7]
Statistical analysis
Statistical analysis was performed using PASW
statistics version 18.0 software (SPSS Inc., Chicago,
IL, USA). Descriptive data were expressed in mean ± standard deviation, number and frequency (%),
or median (min-max) values, unless otherwise stated.
Significance testing was performed by an independent
biostatistician using a two-sample t test for comparisons
between groups (continuous data), either a chi-square
test or a Fisher"s exact test for homogeneity between
groups (categorical data), or Mann-Whitney U test,
when median (range) was presented. A p value of <0.05
was considered statistically significant.
Table 1: Preoperative characteristics of patients
Primary indications for surgery included on-pump coronary artery bypass grafting (CABG) in 101 patients, off-pump CABG (n=8), repair or replacement of one or more valves (n=47) and other procedures (n=18). The distribution of surgical procedures is summarized in Table 2.
An intra-aortic balloon pump was required in four patients (JP group: 2.1%, non-JP group: 2.5%; p=0.63). The median stay in the intensive care unit was two days and the median time from operation to discharge was seven days in both groups.
Surgical outcomes are presented in Table 4. Accordingly, there was no significant difference in reoperation for bleeding or cardiac tamponade between the groups. The complications of sternal site were divided into superficial wound infections and deep sternal complications. Analysis of the primary outcome of SWCs showed statistically significant differences between the groups (Table 4). Sternal wound complications occurred in two patients (2.1%) in the JP group, compared to nine patients (11.25%) in the non-JP group (p=0.01). Superficial wound infection occurred in one patient (1.1%) in the JP group and seven patients (8.75%) in the non-JP group (p=0.02), whereas deep wound infection was seen in one patient (1.1%) in the JP group versus two patients (2.5%) in the non-JP group (p=0.44). The patient with a deep sternal complication in the JP group was a 65-year-old male hypertensive and diabetic patient with a height of 173 cm and body weight 126 kg (BMI 42 kg/m2), underwent CABG. After 30 days from discharging the patient, pressing anterior chest pain due to violent coughing was initiated. On clinical evaluation, the patient showed sternal instability on palpation from the wound. After a control computed tomography scan, it was decided to perform surgical revision of the wound using thermoreactive clips.
Table 4: Comparison of postoperative adverse events between JP and non-JP groups
Mediastinal wound complications are a significant source of postoperative mortality and increased costs.[8] Wound infections can be classified as superficial (skin and/or subcutaneous tissue) or deep (bone and retrosternal space). Despite modern cardiac surgery procedures, the reported incidence of sternal wound infections has not considerably decreased.[9,10] The incidence of superficial sternal infections ranges from 0.9 to 20%.[11,12] The risk factors of sternal wound infections can be classified as preoperative (i.e., diabetes, male gender, obesity), operative (i.e., use of bilateral mammary arteries), and postoperative (i.e., mechanical ventilation) variables.[13-17] Salehi Omran et al.[18] reported that female sex, hypertension, and re-exploration for bleeding were significant risk factors in the development of sternal wound infections.[18] Furnary et al.[19] showed that reducing glucose levels in diabetic patients could decrease the incidence of SWCs after cardiac surgery. In another study, it was reported that hyperglycemia during immediate postoperative period was a risk factor for developing sternal wound infections.[20] Obesity is also known to increase the risk of postoperative SWCs, although the exact mechanisms are not wellunderstood yet and may include hypovascularity of adipose tissue, decreased oxygen tension, compromised collagenization, compromised immunity, oxidative stress, and adiponectin deficiency.[21-25] Consistent with other reports,[15,16] Lu et al.[26] found that obesity was one of the significant risk factors for sternal wound infections. In another study from Ridderstolpe et al.,[13] obese patients were found to be 2.1 times more likely to develop sternal wound infections. Milano et al.[27] suggested that skin preparation could be difficult and inadequate in obese patients.
Considering all these factors, additional preventive measures are needed to decrease the incidence of sternal wound infections, particularly in patients with a BMI of ≥30 kg/m2. Karabay et al.[28] demonstrated an increased rate of superficial sternal wound infections, when the intracutaneous suture technique was used compared to the transcutaneous method. Balkanay et al.[29] reported that using gentamicin-soaked sponges during CABG could decrease sternal wound infections.
A particular attention should be given to patients who have a high BMI, as they have a significantly higher rate of SWCs. Although many techniques for closing median sternotomy in obese patients have been attempted until now, there is no report in the literature regarding the use of JP drains in cardiac surgery.[30,31] The JP suction drains have been used in various areas of surgery including urologic surgery, gynecologic oncology surgery, and after breast reconstruction.[32-34]
In our study, the JP drain was used to prevent fluid build-up in a closed space during healing of sternal wound. We hypothesized that the insertion of the JP drain would help to prevent fluid (blood or other) build-up in a closed space during healing, by reducing the risk of SWCs after median sternotomy. Noveksky et al.[33] inserted a JP drain below the Camper's fascia in women with a BMI of ≥30 kg/m2 who underwent gynecologic surgery. This surgical protocol led to a decreased rate of wound complications among women with a BMI of 30 to 39.9 kg/m2. In our study, we used the JP drain in 94 patients with a BMI of ≥30 kg/m2 undergoing cardiac surgery via median sternotomy. The JP group patients had a significantly lower risk of superficial wound complications compared to the non-JP group (1.1% vs. 8.75%, p=0.02). We believe that superficial sternal infections are important, as they may progress to deeper layers, leading to deep sternum complications.
The incidence of deep sternal wound infection varies from 0.4 to 5%.[35] In addition to physical problems, the patient usually faces with the mental burden of additional surgical procedures, a longer hospital stay, and prolonged intake of antibiotics. These complications are also associated with a considerable financial burden for patients, families, and the entire health care system.[36]
In their study including 2,809 patients, Magedanz et al.[37] identified five risk factors for mediastinitis in patients undergoing CABG including include COPD, obesity, multiple blood transfusions in the postoperative period, surgical intervention, and angina Class IV. In another recently published study, 107 patients developed mediastinitis in a cohort of 18,532 patients who underwent CABG with a mean follow-up of 10.3 years.[38] The authors identified as independent risk factors for developing mediastinitis: COPD, age, male gender, stenosis of the left main coronary artery, DM, and obesity (BMI >30 kg/m2). These last two were also identified as risk factors for mediastinitis after CABG by Sá et al.[39]
In our study, there was no significant difference in hospital stay between the groups. Sternal wound complications occurred in two patients (2.1%) in the JP group, compared to nine patients (11.25%) in the non-JP group (p=0.01). Deep sternal complications rate was 1% for the JP group and 2.5% for the non-JP group (p=0.44). Although there were no statistically significant differences in the development of a postoperative deep wound infection between the groups, the number of patients was higher in the non- JP group.
Furthermore, the use of bilateral mammary arteries is a known contributor to SWC rates.[13] As shown in our study, the use of bilateral mammary arteries was higher in the JP group, and the operation time was longer; however, the number of SWCs was higher in the non-JP group. The use of the JP drain might have probably decreased the rate of SWCs in the JP group.
The major limitations of this study are the retrospective design and small sample size.
In conclusion, Jackson-Pratt drain insertion after median sternotomy in patients with a Body Mass Index of ≥30 kg/m2 undergoing cardiac surgery is a simple and reliable method to decrease fluid (blood or other) collection in a closed space during healing after median sternotomy. Our study results also suggest that the use of suprasternal JP drain for this purpose may reduce the risk of sternal wound complications, compared to the conventional closure technique.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect to
the authorship and/or publication of this article.
Funding
The authors received no financial support for the research
and/or authorship of this article.
1) McGregor WE, Trumble DR, Magovern JA. Mechanical
analysis of midline sternotomy wound closure. J Thorac
Cardiovasc Surg 1999;117:1144-50.
2) Taylor AH, Mitchell AE, Mitchell IM. A 15-year study
of the changing demographics and infection risk in a new
UK cardiac surgery unit. Interact Cardiovasc Thorac Surg
2012;15:390-4.
3) Graf K, Ott E, Vonberg RP, Kuehn C, Haverich A, Chaberny
IF. Economic aspects of deep sternal wound infections. Eur
J Cardiothorac Surg 2010;37:893-6.
4) Sjögren J, Malmsjö M, Gustafsson R, Ingemansson R.
Poststernotomy mediastinitis: a review of conventional
surgical treatments, vacuum-assisted closure therapy and
presentation of the Lund University Hospital mediastinitis
algorithm. Eur J Cardiothorac Surg 2006;30:898-905.
5) Jackson FE, Pratt RA. Silicone rubber 'brain drain".
Zeitschrift für Neurologie 1972;201:92-4.
6) Jackson FE, Pratt RA. Technical report: A silicone rubber
suction drain for drainage of subdural hematomas. Surgery
1971;70:578-9.
7) Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM.
CDC definitions for nosocomial infections, 1988. Am J
Infect Control 1988;16:128-40.
8) El Oakley RM, Wright JE. Postoperative mediastinitis:
classification and management. Ann Thorac Surg
1996;61:1030-6.
9) Sarıkaya S, Büyükbayrak F, Altaş Ö, Yerlikhan O, Fedakar
A, Rabuş M, et al. Thermoreactive nitinol clips for
re-sternotomy in cases of sternal dehiscence. Turk Gogus
Kalp Dama 2013;21:669-75.
10) Durgun M, Durgun ÖS, Özakpınar HR, Eryılmaz AT, Öktem
HF, İnözü E, et al. Approach to of infected sternotomy
wounds in the management of mediastinitis. Turk Gogus
Kalp Dama 2012;20:820-5.
11) Ulicny KS Jr, Hiratzka LF. The risk factors of median sternotomy
infection: a current review. J Card Surg 1991;6:338-51.
12) Loop FD, Lytle BW, Cosgrove DM, Mahfood S, McHenry
MC, Goormastic M, et al. J. Maxwell Chamberlain memorial
paper. Sternal wound complications after isolated coronary
artery bypass grafting: early and late mortality, morbidity,
and cost of care. Ann Thorac Surg 1990;49:179-86.
13) Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg
H. Superficial and deep sternal wound complications:
incidence, risk factors and mortality. Eur J Cardiothorac
Surg 2001;20:1168-75.
14) Ståhle E, Tammelin A, Bergström R, Hambreus A, Nyström
SO, Hansson HE. Sternal wound complications--incidence,
microbiology and risk factors. Eur J Cardiothorac Surg
1997;11:1146-53.
15) Kuduvalli M, Grayson AD, Oo AY, Fabri BM, Rashid
A. Risk of morbidity and in-hospital mortality in obese
patients undergoing coronary artery bypass surgery. Eur J
Cardiothorac Surg 2002;22:787-93.
16) Birkmeyer NJ, Charlesworth DC, Hernandez F, Leavitt BJ,
Marrin CA, Morton JR, et al. Obesity and risk of adverse
outcomes associated with coronary artery bypass surgery.
Northern New England Cardiovascular Disease Study Group.
Circulation 1998;97:1689-94.
17) Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom
M. Obesity is not a risk factor for significant adverse
outcomes after cardiac surgery. Circulation 1996;94:87-92.
18) Salehi Omran A, Karimi A, Ahmadi SH, Davoodi S,
Marzban M, Movahedi N, et al. Superficial and deep sternal
wound infection after more than 9000 coronary artery
bypass graft (CABG): incidence, risk factors and mortality.
BMC Infect Dis 2007;7:112.
19) Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous
intravenous insulin infusion reduces the incidence of deep
sternal wound infection in diabetic patients after cardiac
surgical procedures. Ann Thorac Surg 1999;67:352-60.
20) Trick WE, Scheckler WE, Tokars JI, Jones KC, Reppen ML,
Smith EM, et al. Modifiable risk factors associated with deep
sternal site infection after coronary artery bypass grafting.
J Thorac Cardiovasc Surg 2000;119:108-14.
21) Conolly WB, Hunt TK, Sonne M, Dunphy JE. Influence
of distant trauma on local wound infection. Surg Gynecol
Obstet 1969;128:713-8.
22) Kawai K, Kageyama A, Tsumano T, Nishimoto S, Fukuda
K, Yokoyama S, et al. Effects of adiponectin on growth
and differentiation of human keratinocytes--implication of
impaired wound healing in diabetes. Biochem Biophys Res
Commun 2008;374:269-73.
23) Pierpont YN, Dinh TP, Salas RE, Johnson EL, Wright TG,
Robson MC, et al. Obesity and surgical wound healing:
a current review. ISRN Obes 2014;2014:638936.
24) Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh
K. Adiponectin stimulates angiogenesis in response to
tissue ischemia through stimulation of amp-activated protein
kinase signaling. J Biol Chem 2004;279:28670-4.
25) Shipman AR, Millington GW. Obesity and the skin. Br J
Dermatol 2011;165:743-50.
26) Lu JC, Grayson AD, Jha P, Srinivasan AK, Fabri BM. Risk
factors for sternal wound infection and mid-term survival
following coronary artery bypass surgery. Eur J Cardiothorac
Surg 2003;23:943-9.
27) Milano CA, Kesler K, Archibald N, Sexton DJ, Jones RH.
Mediastinitis after coronary artery bypass graft surgery. Risk
factors and long-term survival. Circulation 1995;92:2245-51.
28) Karabay O, Fermanci E, Silistreli E, Aykut K, Yurekli I,
Catalyurek H, et al. Intracutaneous versus transcutaneous
suture techniques: comparison of sternal wound infection
rates in open-heart surgery patients. Tex Heart Inst J
2005;32:277-82.
29) Balkanay OO, Göksedef D, Göde S, Kılıç Z, Ömeroğlu SN,
İpek G. Does locally administered gentamicin affect the
incidence of sternal wound infections after coronary artery
bypass graft surgery?. Turk Gogus Kalp Dama 2015;23:32-8.
30) Bennett-Guerrero E, Ferguson TB Jr, Lin M, Garg J,
Mark DB, Scavo VA Jr, et al. Effect of an implantable
gentamicin-collagen sponge on sternal wound infections
following cardiac surgery: a randomized trial. JAMA
2010;304:755-62.
31) Molina JE, Lew RS, Hyland KJ. Postoperative sternal
dehiscence in obese patients: incidence and prevention. Ann
Thorac Surg 2004;78:912-7.
32) Deture FA. Use of Jackson-Pratt flat suction drain in urologic
surgery. Urology 1979;14:520-1.
33) Novetsky AP, Zighelboim I, Guntupalli SR, Ioffe YJ, Kizer
NT, Hagemann AR, et al. A phase II trial of a surgical protocol
to decrease the incidence of wound complications in obese
gynecologic oncology patients. Gynecol Oncol 2014;134:233-7.
34) Phillips BT, Wang ED, Mirrer J, Lanier ST, Khan SU,
Dagum AB, et al. Current practice among plastic surgeons
of antibiotic prophylaxis and closed-suction drains in breast
reconstruction: experience, evidence, and implications for
postoperative care. Ann Plast Surg 2011;66:460-5.
35) Hollenbeak CS, Murphy DM, Koenig S, Woodward RS,
Dunagan WC, Fraser VJ. The clinical and economic impact
of deep chest surgical site infections following coronary
artery bypass graft surgery. Chest 2000;118:397-402.
36) Speir AM, Kasirajan V, Barnett SD, Fonner E Jr. Additive
costs of postoperative complications for isolated coronary
artery bypass grafting patients in Virginia. Ann Thorac Surg
2009;88:40-5.
37) Magedanz EH, Bodanese LC, Guaragna JC, Albuquerque
LC, Martins V, Minossi SD, et al. Risk score elaboration for
mediastinitis after coronary artery bypass grafting. Rev Bras
Cir Cardiovasc 2010;25:154-9.